Bausch Health Companies Inc. (NYSE: BHC) completed its acquisition of DURECT Corporation for $1.75 per share in cash, totaling approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE